Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 34

Trial Status

Completed2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04051463Phase 2/3Completed
Rhopressa for Corneal Edema Associated With Fuchs Dystrophy
Fuchs Endothelial Dystrophy
PrincipalinvestigatorStart date: 2019-08-05
NCT03971357Phase 2/3Terminated
Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration
Fuchs' Endothelial Dystrophy
PrincipalinvestigatorStart date: 2019-07-22
NCT04018417Phase 2/3Withdrawn
Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.
Fuchs' Endothelial Dystrophy
PrincipalinvestigatorStart date: 2019-07-03
NCT03248037Phase 3Completed
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Bullous KeratopathyFuchs' Endothelial Dystrophy
PrincipalinvestigatorStart date: 2017-09-05

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Price Vision Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francis W Price, MD

Price Vision Group

Moderately Similar
3 trials

Shared therapeutic areas:

Bullous KeratopathyFuchs' Endothelial Dystrophy

Worked with same sponsors:

Cornea Research Foundation of AmericaPrice Vision Group
Similarity Score30%

Valeria Sanchez Huerta, MD

Asociacion para Evitar la Ceguera

Moderately Similar
2 trials

Shared therapeutic areas:

Bullous KeratopathyFuchs' Endothelial Dystrophy
Similarity Score30%

Carina Koppen, MD, PhD

University Hospital, Antwerp

Moderately Similar
2 trials

Shared therapeutic areas:

Bullous KeratopathyFuchs' Endothelial Dystrophy
Similarity Score30%

Edward J Holland, MD

University of Cincinnati and Cincinnati Eye Institute

Related
1 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Thomas Tremblay

Trefoil Therapeutics.com

Related
3 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Olav Kristianslund, MD PhD

Department of Ophthalmology, Oslo University Hospital

Related
3 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Mark A Terry, MD

Devers Eye Institute

Related
2 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Mark J Mannis, MD

University of California, Davis

Related
1 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Emma E Davies

Massachusetts Eye and Ear Infirmary

Related
1 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Jean-Marc PERONE, MD

CHR Metz Thionville Hopital de Mercy

Related
3 trials

Shared therapeutic areas:

Fuchs' Endothelial Dystrophy
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04051463Phase 2/3PrincipalInvestigator

Rhopressa for Corneal Edema Associated With Fuchs Dystrophy

Fuchs Endothelial Dystrophy
Completed
NCT03971357Phase 2/3PrincipalInvestigator

Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration

Fuchs' Endothelial Dystrophy
Terminated
NCT04018417Phase 2/3PrincipalInvestigator

Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.

Fuchs' Endothelial Dystrophy
Withdrawn
NCT03248037Phase 3PrincipalInvestigator

Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation

Bullous KeratopathyFuchs' Endothelial Dystrophy
Completed

All 4 trials loaded